Alkem Laboratories Ltd
BSE:539523
Alkem Laboratories Ltd
BSE:539523
Price:
5 298.2
INR
2.97%
Market Closed
Market Cap:
₹633.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Alkem Laboratories Ltd
BSE:539523
|
IN |
|
Federal Mogul Izmit Piston ve Pim Uretim Tesisleri AS
IST:FMIZP.E
|
TR |
|
Z
|
Zura Bio Ltd
NASDAQ:ZURA
|
US |
|
Shenzhen Absen Optoelectronic Co Ltd
SZSE:300389
|
CN |
|
Jayaswal Neco Industries Ltd
NSE:JAYNECOIND
|
IN |
|
A
|
Alpha Tau Medical Ltd
NASDAQ:DRTS
|
IL |
|
Porr AG
LSE:0J04
|
AT |
|
C
|
CanariaBio Inc
KOSDAQ:016790
|
KR |
|
Guararapes Confeccoes SA
BOVESPA:GUAR3
|
BR |
|
Motilal Oswal Financial Services Ltd
NSE:MOTILALOFS
|
IN |
|
China Mobile Ltd
SSE:600941
|
CN |
Relative Value
The Relative Value of one
ALKEM
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 5 298.2 INR,
Alkem Laboratories Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALKEM Relative Value
HIDDEN
Multiples Across Competitors
ALKEM Competitors Multiples
Alkem Laboratories Ltd Competitors
Alkem Laboratories Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Alkem Laboratories Ltd
BSE:539523
|
633.3B INR | 4.6 | 27.4 | 21.1 | 24.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 13.3 | 42 | 28.3 | 30.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.4B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD | 4.5 | 16.1 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.2B GBP | 5 | 28.6 | 15.9 | 22.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.4B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.3B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.5B USD | 2.5 | 16.8 | 7.1 | 8.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
